Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals KLOW Blend 80mg Koi Peptides FDA mulls compounding for peptides previously flagged over safety risks BioSpace When will the FDA reclassify BPC 157 to Category 1 Octagon AI This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step